Voglimark GM 2mg/500mg/0.2mg Tablet SR
Marketer
Unimarck Healthcare Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Voglimark GM 2mg/500mg/0.2mg Tablet SR
Diabetic patients utilizing the anti-diabetic medication, Voglimark GM 2mg/500mg/0.2mg SR tablet, should understand its combined-drug formulation for managing type 2 diabetes in adults. This medication aids in blood glucose regulation, requiring consistent daily intake at the same time, preferably with food. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial, even with controlled blood sugar, as abrupt cessation can lead to dangerously elevated glucose levels and potential complications including renal impairment, vision loss, neuropathy, and limb amputation. This medication forms part of a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your healthcare professional. Hypoglycemia (low blood sugar) is a prevalent side effect; learn to identify symptoms (sweating, dizziness, headache, tremors) and have readily available fast-acting glucose (e.g., sugary snacks, juice). Alcohol consumption increases hypoglycemia risk and should be avoided. Other potential adverse effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, edema, visual disturbances, bone fractures, upper respiratory infections, and weight gain. This medication is contraindicated for individuals with type 1 diabetes, diabetic ketoacidosis, or significant hepatic or renal dysfunction. Prior heart disease should be disclosed to your doctor before commencing treatment, as well as pregnancy or breastfeeding status. Regular blood sugar checks, complete blood counts, and liver function tests may be recommended by your physician.
Uses of Voglimark GM 2mg/500mg/0.2mg Tablet SR
Managing Type 2 diabetes
Major Benefits of Voglimark GM 2mg/500mg/0.2mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Voglimark GM 2mg/500mg/0.2mg Tablet SR whole; avoid chewing, crushing, or fracturing. Administer on an empty stomach.
Common Side effects of Voglimark GM 2mg/500mg/0.2mg Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Voglimark GM 2mg/500mg/0.2mg Tablet SR:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and schedule. Ingest the Voglimark GM 2mg/500mg/0.2mg Tablet SR whole; avoid chewing, crushing, or fracturing. Consume it on an empty stomach.
How Voglimark GM 2mg/500mg/0.2mg Tablet SR works:
Voglimark GM, a sustained-release tablet containing 2mg/500mg/0.2mg of three distinct antidiabetic agents, is a triple-combination therapy.
SAFETY ADVICE
AlcoholUNSAFE
Combining Voglimark GM 2mg/500mg/0.2mg SR tablets with alcohol is hazardous.
PregnancyCONSULT YOUR DOCTOR
The use of Voglimark GM 2mg/500mg/0.2mg Extended-Release tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks before prescribing this medication. Patient consultation with their doctor is advised.
Breast feedingCONSULT YOUR DOCTOR
Breastfeeding while taking Voglimark GM 2mg/500mg/0.2mg Tablet SR is likely inadvisable. Available human data indicates potential drug transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar irregularities.
KidneyUNSAFE
Employing Voglimark GM 2mg/500mg/0.2mg Tablet SR in individuals with kidney impairment poses a likely risk and should be forgone. Medical advice is recommended. Furthermore, its use is contraindicated for patients exhibiting severe kidney dysfunction.
LiverCAUTION
Patients with liver impairment should use Voglimark GM 2mg/500mg/0.2mg SR tablets cautiously, potentially requiring dose modification. Physician consultation is advised. In individuals with mild to moderate hepatic dysfunction, initiation should be at a low dosage; its use is contraindicated in those with severe liver disease.
What if you forget to take Voglimark GM 2mg/500mg/0.2mg Tablet SR :
Should you forget to take a Voglimark GM 2mg/500mg/0.2mg Tablet SR, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Voglimark GM 2mg/500mg/0.2mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently